Summary
- Psychedelic-assisted therapy
- Ketamine micro-dosing
- CBD and THC micro-dosing
Psychedelic-assisted therapy
In 2024, there has been a growing interest in the use of psychedelics such as psilocybin and MDMA in micro-dosing therapies for mental health. Research has shown promising results in treating conditions like depression, PTSD, and anxiety.
Ketamine micro-dosing
Ketamine, traditionally used as an anesthetic, has gained attention for its potential in micro-dosing therapies for mental health. Studies have indicated its effectiveness in treating treatment-resistant depression and other mood disorders.
CBD and THC micro-dosing
In recent years, there has been a surge in the use of CBD and THC micro-dosing for mental health conditions. These cannabinoids have shown potential in alleviating symptoms of anxiety, depression, and PTSD, with minimal psychoactive effects.